PRINCIPLES OF TOXICOLOGY

REFERENCES AND SUGGESTED READING
REFERENCES AND SUGGESTED READING 497
ATSDR (Agency for Toxic Substances and Disease Registry), Toxicological Profile for Lead. Draft for Public
Comment (update), U.S. Department of Health and Human Services, Aug. 1997.
ASTM (American Society for Testing and Materials), Standard Guide for Risk-Based Corrective Action Applied
at Petroleum Release Sites, E1739-95, 1995.
Bhumbla, D. K., and R. F. Keefer, “Arsenic mobilization and bioavailability in soils,” in Arsenic in the Environment,
Part I: Cycling and Characterization, J. O. Nriagu, ed., Wiley, New York, 1994, p. 51.
Binder, S., D. Forney, W. Kaye, D. Paschal, “Arsenic exposure in children living near a former copper smelter,”
Bull. Environ. Contam. Toxicol. 39: 114–121 (1987).
Binder, S., “The case for the NEDEL (the no epidemiologically detectable exposure level,” Am. J. Publ. Health
78: 589–590 (1988).
CalEPA, Public Health Goal for Antimony in Drinking Water, prepared by the Pesticide and Environmental
Toxicology Section, Office of Environmental Health Hazard Assessment, California Environmental Protection
Agency; draft for public comment and scientific review, Nov. 1997.
Dourson, M. L., and J. F. Stara, “Regulatory history and experimental support of uncertainty (safety) factors,” Reg.
Toxicol. Pharmacol. 3: 224–238 (1983).
Eastern Research Group, Report on the Expert Panel on Arsenic Carcinogenicity: Review and Workshop, National
Center for Environmental Assessment. U.S. Environmental Protection Agency, Aug. 1997.
Freeman, G. B., R. A. Schoof, M. V. Ruby, A. O. Davis, J. A. Dill, S. C. Liao, C. A. Lapin, and P. D. Bergstrom,
“Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration
in cynomolgus monkeys,” Fund. Appl. Toxicol. 28: 215–222 (1995).
Groth, D. H., L. E. Stettler, J. R. Burg, W. M. Busey, G. C. Grant, and L. Wong, “Carcinogenic effects of antimony
trioxide and antimony ore concentrate in rats,” J. Toxicol. Environ. Health 18(4): 607–626 (1986).
Hewitt, D. J., G. C. Millner, A. C. Nye, M. Webb, R. G. Huss, “Evaluation of residential exposure to arsenic in soil
near a Superfund site,” Hum. Ecol. Risk Assess. 1: 323–335 (1995).
Hext, P. M., “Current perspectives on particulate induced pulmonary tumors,” Hum. Exp. Toxicol. 13: 700–715
(1994).
IRIS (Integrated Risk Information Service), USEPA database accessed on Dec. 12, 1998.
Kalman, D. A., J. Hughes, G. van Belle, T. Burbacher, D. Bolgiano, K. Coble, N. K. Mottet, and L. Polissar. “The
effect of variable environmental arsenic contamination on urinary concentrations of arsenic species,” Environ.
Health Persp. 89: 145–151 (1990).
MADEP (Massachusetts Department of Environmental Protection), Characterizing Risks Posed by Petroleum
Contaminated Sites: Implementation of MADEP VPH/EPH Approach, Public Comment Draft, Sept. 23, 1997.
Morrow, P. E., “Dust overloading of the lungs: Update and reappraisal,” Toxicol. Appl. Pharmacol. 113: 1–12
(1992).
Newton, P. E., H. F. Bolte, I. W. Daly, B. D. Pillsbury, J. B. Terrill, R. T. Drew, R. Ben-Dyke, A. W. Sheldon, and
L. F. Rubin, “Subchronic and chronic inhalation toxicity of antimony trioxide in the rat,” Fund. Appl. Toxicol.
22: 561–576 (1994).
Nikula, K. J., K. J. Avila, W. C. Griffith, and J. L. Mauderly, Lung tissue responses and sites of particle retention
differ between rats and cynomolgus monkeys exposed chronically to diesel exhaust and coal dust, Fund. Appl.
Toxicol. 37: 37–53 (1997).
NRC (National Research Council), Science and Judgment in Risk Assessment, National Academy Press, Washington,
1994.
Presidential/Congressional Commission on Risk Assessment and Risk Management, Risk Assessment and Risk
Management in Regulatory Decision-Making, Final Report, Vol. 2, 1997.
Pritchard, J. N., “Dust overloading causes impairment of pulmonary clearance: Evidence from rats and humans,”
Exp. Pathol. 37(1–4): 39–42 (1989).
Rudel, R., T. M. Slayton, and B. D. Beck, “ Implications of arsenic genotoxicity for dose response of carcinogenic
effects,” Reg. Toxicol. Pharmacol. 23: 87–105 (1996).
Schultz, M., “Comparative pathology of dust-induced pulmonary lesions: Significance of animal studies to
humans,” Inhalation Toxicol. 8: 433–456 (1996).